Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

A sizable medical device company and a handful of small issuers went public in the first week of March, though a ...

(MENAFN- Investor Ideas) Investorideas , a recognized top 100 investment site for stock news announces today's IPO's to watch in the Biotech, Technology, Homebuilder, Aerospace and Sporting sectors.

Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs ...

Malaysia's biotechnology and bio-based industries have emerged as crucial drivers of the country's economic development, ...

The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

After hitting a record high in 2021, the number of biotech IPOs have fallen to a yearly average in the 20s, with most successful entries in the last few quarters involving companies with mid- to ...

Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...

Bluejay Therapeutics, a drug developer focused on serious viral and liver diseases, is considering a US initial public offering, according to people familiar with the matter.

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

March 7, 2025 (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces today's IPO's to watch in the Biotech, Technology, Homebuilder ...